Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens



Sawant, N; Kaur, K; Holland, DA; Hickey, JM; Agarwal, S; Brady, JR; Dalvie, NC; … Volkin, DB; + view all Sawant, N; Kaur, K; Holland, DA; Hickey, JM; Agarwal, S; Brady, JR; Dalvie, NC; Tracey, MK; Velez-Suberbie, ML; Morris, SA; Jacob, SI; Bracewell, DG; Mukhopadhyay, TK; Love, KR; Love, JC; Joshi, SB; Volkin, DB; – view fewer (2020) Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens. Journal of Pharmaceutical Sciences 10.1016/j.xphs.2020.11.039 . (In press). Green open access

Source link

Comments are closed, but trackbacks and pingbacks are open.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy